A Legal Review of ‘Best Efforts’ Clauses: Focusing on COVID-19 Vaccine Purchase Contracts
Lists
Only you see this
Abstract
Since the World Health Organization (WHO) on March 11, 2020, declared the novel coronavirus (COVID-19) outbreak a global pandemic, many countries around the world have experienced contractual inequality in their dealings with global vaccine developers, such as delayed deliveries, limitations of liability for claims, disclaimers of warranties, and excessive confidentiality when negotiating purchase contracts. In 2021, the EU Commission filed a lawsuit in Brussels against AstraZeneca for not keeping to its purchase agreement for the supply of COVID-19 vaccines. This study reviews the best-efforts clauses in the vaccine contracts signed by the EU and AstraZeneca focusing on the legal effects and duties of such clauses. The concept of the best-efforts clause is analyzed from a legal perspective, including its function and theoretical background in comparative law. This study methodically reviews the best-efforts clause within the COVID-19 vaccine advance purchase contract between the EU and AstraZeneca in September 2020, and analyzes the European Union’s civil suit against AstraZeneca, filed in Belgium, for the delay in delivery of vaccines to the European Union. Consequently, this paper intends to present practical implications for the legal effects and duties of best-efforts clauses in the vaccine purchase agreements in the European Union v. AstraZeneca case.
BibTeX
@inproceedings{kim2022legal,
author = {Jinkyu Kim},
title = {{A Legal Review of ‘Best Efforts’ Clauses: Focusing on COVID-19 Vaccine Purchase Contracts}},
booktitle = {Korea},
year = {2022},
doi = {10.15798/kaici.2022.24.3.175},
}Loading related content...